查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1866631

採血針：2025-2031年全球市佔率與排名、總收入與需求預測

Lancets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024年全球採血針市場規模估計為 16.73億美元，預計到2031年將成長至20.56億美元，2025年至2031年的年複合成長率為 3.0%。

本報告對近期關稅調整和國際戰略反制措施對採血針跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響進行了全面評估。

採血針是用於採集血液樣本進行檢測的針頭。心血管和內分泌併發症患者使用採血針的情況日益增多。採血針設計為一次性使用，用後可安全丟棄。這些器械用於膽固醇和血糖值檢測、新生兒足跟血篩檢和苯酮尿症（PKU）檢測、嚴重燒燙傷或疤痕的急診病患、極度肥胖患者以及易患血栓的患者。預計到2024年，全球採血針產量將達到約 553.7億支，全球平均市場價格約為每千支 30.22 美元。

市場促進因素：

慢性病發生率上升：糖尿病等需要定期監測血糖值的慢性病發生率上升，是採血針需求成長的主要促進因素。隨著全球糖尿病患者人數的增加，對採血針的需求也持續成長。

採血針技術的進步：超細針頭、無痛設計和易於使用的採血針裝置等創新改善使用者體驗，使採血更加舒適，鼓勵更頻繁地使用。

居家醫療的興起：居家醫療和各種疾病（尤其是糖尿病）的自我管理趨勢推動採血針的使用，使患者能夠以更方便、更經濟有效的方式管理自己的健康狀況，擴大了這些設備的市場。

社會老化：隨著人口老化，越來越多的人患有糖尿病等慢性疾病，需要定期進行血液監測。這種人口結構變化是推動採血針和其他監測設備需求成長的主要因素。

提高預防保健意識：人們越來越意識到定期保健的重要性，尤其是在糖尿病等疾病的管理方面，這推動了採血針在常規血液檢測和血糖值監測中的應用。

市場挑戰：

來自替代技術的競爭：非侵入性血糖監測方法（如連續血糖監測儀和基於感測器的系統）越來越受歡迎，可能會減少對採血採血針的依賴。

患者的持續成本：採血針是一次性醫療設備，對於需要頻繁檢測的患者來說，持續的成本可能會造成經濟負擔，尤其是對於低收入地區和沒有保險的患者而言，這可能會限制市場成長。

感染風險：採血針使用不當或重複使用，尤其是處理不當或意外重複使用時，會導致感染疾病，造成健康風險，並降低人們使用採血針的動機。

環境問題：由於採血針是一次性醫療設備，它們會產生醫療廢棄物，並引發人們對其對環境影響的擔憂，這可能會導致監管壓力增加，並促使人們轉向更永續的替代品。

監管合規和核准障礙：採血針市場受到衛生當局嚴格的監管和核准程序，可能會延遲新產品和創新的推出，並阻礙其市場供應。

本報告目的是對全球採血針市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名，並依地區/國家、類型和應用進行分析。

採血針市場規模、估計和預測以銷售（百萬支）和收入（百萬美元）為單位呈現，以2024年為基準年，並包括2020年至2031年期間的歷史資料和預測資料。報告採用定量和定性分析相結合的方法，幫助讀者制定業務/成長策略、評估市場競爭、分析自身在當前市場中的地位，並就採血針做出明智的決策。

市場區隔

公司

  • Roche
  • Lifescan
  • BD
  • MTD Group
  • Greiner Bio One
  • Owen Mumford
  • Cardinal Health
  • Ascensia
  • Abbott
  • B. Braun
  • Terumo
  • I-SENS
  • Nipro
  • ICU Medical
  • Sarstedt
  • Sinocare
  • Yueyue Medical
  • Tianjin Huahong Medical
  • Suzhou Shilai Medical
  • Shandong Lianfa Medical
  • Promisemed

依類型

  • 安全採血針
  • 普通採血針

依應用

  • 血糖測量
  • 新生兒篩檢
  • 快速血液檢測
  • 其他

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Lancets was estimated to be worth US$ 1673 million in 2024 and is forecast to a readjusted size of US$ 2056 million by 2031 with a CAGR of 3.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Lancets cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.In 2024, global Lancets production reached approximately 55.37 billion units, with an average global market price of around 30.22 US$ / k unit.

Market Drivers:

Growing prevalence of chronic diseases: The rise in chronic conditions like diabetes, which require regular blood glucose monitoring, is a significant driver for lancet demand. As the number of diabetes patients increases globally, the need for lancets continues to grow.

Technological advancements in lancets: Innovations such as ultra-thin needles, painless lancet designs, and easy-to-use lancet devices improve user experience, making blood sampling more comfortable and encouraging more frequent use.

Increase in home-based healthcare: The trend toward home healthcare and self-monitoring for various conditions, especially diabetes, has driven the use of lancets. This allows patients to monitor their health in a more convenient and cost-effective way, increasing the market for these devices.

Aging population: The growing elderly population is more prone to chronic diseases like diabetes, requiring regular blood monitoring. This demographic shift is a major factor pushing the demand for lancets and other monitoring devices.

Rising awareness of preventive healthcare: Increasing awareness of the importance of regular health monitoring, especially for managing conditions like diabetes, has led to higher adoption of lancets for routine blood tests and glucose monitoring.

Market Challenges:

Competition from alternative technologies: Non-invasive blood glucose monitoring methods (such as continuous glucose monitors or sensor-based systems) are gaining traction, potentially reducing the reliance on traditional lancets for blood sampling.

High recurring costs for patients: Lancets are single-use devices, and the recurring cost for people who need frequent testing can become a financial burden, particularly in low-income regions or for uninsured patients, limiting market growth.

Infection risks: Improper or repeated use of lancets can lead to infections, particularly if they are not disposed of properly or if reused by mistake, which poses a health risk and deters their use.

Environmental concerns: Lancets contribute to medical waste, as they are disposable devices, raising concerns about environmental impact. This could lead to regulatory pressures or a shift toward more sustainable alternatives.

Regulatory compliance and approval hurdles: The lancet market is subject to stringent regulations and approval processes from health authorities. This can slow down the introduction of new products and innovations, delaying their availability in the market.

This report aims to provide a comprehensive presentation of the global market for Lancets, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lancets by region & country, by Type, and by Application.

The Lancets market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lancets.

Market Segmentation

By Company

  • Roche
  • Lifescan
  • BD
  • MTD Group
  • Greiner Bio One
  • Owen Mumford
  • Cardinal Health
  • Ascensia
  • Abbott
  • B. Braun
  • Terumo
  • I-SENS
  • Nipro
  • ICU Medical
  • Sarstedt
  • Sinocare
  • Yueyue Medical
  • Tianjin Huahong Medical
  • Suzhou Shilai Medical
  • Shandong Lianfa Medical
  • Promisemed

Segment by Type

  • Safety Lancets
  • Ordinary Lancets

Segment by Application

  • Blood Glucose Test
  • Newborn Screening
  • Rapid Blood Test
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Lancets in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Lancets Product Introduction
  • 1.2 Global Lancets Market Size Forecast
    • 1.2.1 Global Lancets Sales Value (2020-2031)
    • 1.2.2 Global Lancets Sales Volume (2020-2031)
    • 1.2.3 Global Lancets Sales Price (2020-2031)
  • 1.3 Lancets Market Trends & Drivers
    • 1.3.1 Lancets Industry Trends
    • 1.3.2 Lancets Market Drivers & Opportunity
    • 1.3.3 Lancets Market Challenges
    • 1.3.4 Lancets Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Lancets Players Revenue Ranking (2024)
  • 2.2 Global Lancets Revenue by Company (2020-2025)
  • 2.3 Global Lancets Players Sales Volume Ranking (2024)
  • 2.4 Global Lancets Sales Volume by Company Players (2020-2025)
  • 2.5 Global Lancets Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Lancets Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Lancets Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Lancets
  • 2.9 Lancets Market Competitive Analysis
    • 2.9.1 Lancets Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Lancets Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lancets as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Safety Lancets
    • 3.1.2 Ordinary Lancets
  • 3.2 Global Lancets Sales Value by Type
    • 3.2.1 Global Lancets Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Lancets Sales Value, by Type (2020-2031)
    • 3.2.3 Global Lancets Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Lancets Sales Volume by Type
    • 3.3.1 Global Lancets Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Lancets Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Lancets Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Lancets Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Blood Glucose Test
    • 4.1.2 Newborn Screening
    • 4.1.3 Rapid Blood Test
    • 4.1.4 Other
  • 4.2 Global Lancets Sales Value by Application
    • 4.2.1 Global Lancets Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Lancets Sales Value, by Application (2020-2031)
    • 4.2.3 Global Lancets Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Lancets Sales Volume by Application
    • 4.3.1 Global Lancets Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Lancets Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Lancets Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Lancets Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Lancets Sales Value by Region
    • 5.1.1 Global Lancets Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Lancets Sales Value by Region (2020-2025)
    • 5.1.3 Global Lancets Sales Value by Region (2026-2031)
    • 5.1.4 Global Lancets Sales Value by Region (%), (2020-2031)
  • 5.2 Global Lancets Sales Volume by Region
    • 5.2.1 Global Lancets Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Lancets Sales Volume by Region (2020-2025)
    • 5.2.3 Global Lancets Sales Volume by Region (2026-2031)
    • 5.2.4 Global Lancets Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Lancets Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Lancets Sales Value, 2020-2031
    • 5.4.2 North America Lancets Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Lancets Sales Value, 2020-2031
    • 5.5.2 Europe Lancets Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Lancets Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Lancets Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Lancets Sales Value, 2020-2031
    • 5.7.2 South America Lancets Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Lancets Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Lancets Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Lancets Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Lancets Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Lancets Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Lancets Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Lancets Sales Value, 2020-2031
    • 6.3.2 United States Lancets Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Lancets Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Lancets Sales Value, 2020-2031
    • 6.4.2 Europe Lancets Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Lancets Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Lancets Sales Value, 2020-2031
    • 6.5.2 China Lancets Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Lancets Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Lancets Sales Value, 2020-2031
    • 6.6.2 Japan Lancets Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Lancets Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Lancets Sales Value, 2020-2031
    • 6.7.2 South Korea Lancets Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Lancets Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Lancets Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Lancets Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Lancets Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Lancets Sales Value, 2020-2031
    • 6.9.2 India Lancets Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Lancets Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Roche
    • 7.1.1 Roche Company Information
    • 7.1.2 Roche Introduction and Business Overview
    • 7.1.3 Roche Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Roche Lancets Product Offerings
    • 7.1.5 Roche Recent Development
  • 7.2 Lifescan
    • 7.2.1 Lifescan Company Information
    • 7.2.2 Lifescan Introduction and Business Overview
    • 7.2.3 Lifescan Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Lifescan Lancets Product Offerings
    • 7.2.5 Lifescan Recent Development
  • 7.3 BD
    • 7.3.1 BD Company Information
    • 7.3.2 BD Introduction and Business Overview
    • 7.3.3 BD Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 BD Lancets Product Offerings
    • 7.3.5 BD Recent Development
  • 7.4 MTD Group
    • 7.4.1 MTD Group Company Information
    • 7.4.2 MTD Group Introduction and Business Overview
    • 7.4.3 MTD Group Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 MTD Group Lancets Product Offerings
    • 7.4.5 MTD Group Recent Development
  • 7.5 Greiner Bio One
    • 7.5.1 Greiner Bio One Company Information
    • 7.5.2 Greiner Bio One Introduction and Business Overview
    • 7.5.3 Greiner Bio One Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Greiner Bio One Lancets Product Offerings
    • 7.5.5 Greiner Bio One Recent Development
  • 7.6 Owen Mumford
    • 7.6.1 Owen Mumford Company Information
    • 7.6.2 Owen Mumford Introduction and Business Overview
    • 7.6.3 Owen Mumford Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Owen Mumford Lancets Product Offerings
    • 7.6.5 Owen Mumford Recent Development
  • 7.7 Cardinal Health
    • 7.7.1 Cardinal Health Company Information
    • 7.7.2 Cardinal Health Introduction and Business Overview
    • 7.7.3 Cardinal Health Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Cardinal Health Lancets Product Offerings
    • 7.7.5 Cardinal Health Recent Development
  • 7.8 Ascensia
    • 7.8.1 Ascensia Company Information
    • 7.8.2 Ascensia Introduction and Business Overview
    • 7.8.3 Ascensia Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Ascensia Lancets Product Offerings
    • 7.8.5 Ascensia Recent Development
  • 7.9 Abbott
    • 7.9.1 Abbott Company Information
    • 7.9.2 Abbott Introduction and Business Overview
    • 7.9.3 Abbott Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Abbott Lancets Product Offerings
    • 7.9.5 Abbott Recent Development
  • 7.10 B. Braun
    • 7.10.1 B. Braun Company Information
    • 7.10.2 B. Braun Introduction and Business Overview
    • 7.10.3 B. Braun Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 B. Braun Lancets Product Offerings
    • 7.10.5 B. Braun Recent Development
  • 7.11 Terumo
    • 7.11.1 Terumo Company Information
    • 7.11.2 Terumo Introduction and Business Overview
    • 7.11.3 Terumo Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Terumo Lancets Product Offerings
    • 7.11.5 Terumo Recent Development
  • 7.12 I-SENS
    • 7.12.1 I-SENS Company Information
    • 7.12.2 I-SENS Introduction and Business Overview
    • 7.12.3 I-SENS Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 I-SENS Lancets Product Offerings
    • 7.12.5 I-SENS Recent Development
  • 7.13 Nipro
    • 7.13.1 Nipro Company Information
    • 7.13.2 Nipro Introduction and Business Overview
    • 7.13.3 Nipro Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Nipro Lancets Product Offerings
    • 7.13.5 Nipro Recent Development
  • 7.14 ICU Medical
    • 7.14.1 ICU Medical Company Information
    • 7.14.2 ICU Medical Introduction and Business Overview
    • 7.14.3 ICU Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 ICU Medical Lancets Product Offerings
    • 7.14.5 ICU Medical Recent Development
  • 7.15 Sarstedt
    • 7.15.1 Sarstedt Company Information
    • 7.15.2 Sarstedt Introduction and Business Overview
    • 7.15.3 Sarstedt Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Sarstedt Lancets Product Offerings
    • 7.15.5 Sarstedt Recent Development
  • 7.16 Sinocare
    • 7.16.1 Sinocare Company Information
    • 7.16.2 Sinocare Introduction and Business Overview
    • 7.16.3 Sinocare Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Sinocare Lancets Product Offerings
    • 7.16.5 Sinocare Recent Development
  • 7.17 Yueyue Medical
    • 7.17.1 Yueyue Medical Company Information
    • 7.17.2 Yueyue Medical Introduction and Business Overview
    • 7.17.3 Yueyue Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Yueyue Medical Lancets Product Offerings
    • 7.17.5 Yueyue Medical Recent Development
  • 7.18 Tianjin Huahong Medical
    • 7.18.1 Tianjin Huahong Medical Company Information
    • 7.18.2 Tianjin Huahong Medical Introduction and Business Overview
    • 7.18.3 Tianjin Huahong Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Tianjin Huahong Medical Lancets Product Offerings
    • 7.18.5 Tianjin Huahong Medical Recent Development
  • 7.19 Suzhou Shilai Medical
    • 7.19.1 Suzhou Shilai Medical Company Information
    • 7.19.2 Suzhou Shilai Medical Introduction and Business Overview
    • 7.19.3 Suzhou Shilai Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Suzhou Shilai Medical Lancets Product Offerings
    • 7.19.5 Suzhou Shilai Medical Recent Development
  • 7.20 Shandong Lianfa Medical
    • 7.20.1 Shandong Lianfa Medical Company Information
    • 7.20.2 Shandong Lianfa Medical Introduction and Business Overview
    • 7.20.3 Shandong Lianfa Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Shandong Lianfa Medical Lancets Product Offerings
    • 7.20.5 Shandong Lianfa Medical Recent Development
  • 7.21 Promisemed
    • 7.21.1 Promisemed Company Information
    • 7.21.2 Promisemed Introduction and Business Overview
    • 7.21.3 Promisemed Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.21.4 Promisemed Lancets Product Offerings
    • 7.21.5 Promisemed Recent Development

8 Industry Chain Analysis

  • 8.1 Lancets Industrial Chain
  • 8.2 Lancets Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Lancets Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Lancets Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Lancets Market Trends
  • Table 2. Lancets Market Drivers & Opportunity
  • Table 3. Lancets Market Challenges
  • Table 4. Lancets Market Restraints
  • Table 5. Global Lancets Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Lancets Revenue Market Share by Company (2020-2025)
  • Table 7. Global Lancets Sales Volume by Company (2020-2025) & (M Units)
  • Table 8. Global Lancets Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Lancets Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Lancets Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Lancets Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Lancets
  • Table 13. Global Lancets Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lancets as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Lancets Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Lancets Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Lancets Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Lancets Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Lancets Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Lancets Sales Volume by Type: 2020 VS 2024 VS 2031 (M Units)
  • Table 22. Global Lancets Sales Volume by Type (2020-2025) & (M Units)
  • Table 23. Global Lancets Sales Volume by Type (2026-2031) & (M Units)
  • Table 24. Global Lancets Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Lancets Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Lancets Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Lancets Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Lancets Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Lancets Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Lancets Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Lancets Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Lancets Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Lancets Sales Volume by Application: 2020 VS 2024 VS 2031 (M Units)
  • Table 34. Global Lancets Sales Volume by Application (2020-2025) & (M Units)
  • Table 35. Global Lancets Sales Volume by Application (2026-2031) & (M Units)
  • Table 36. Global Lancets Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Lancets Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Lancets Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Lancets Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Lancets Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Lancets Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Lancets Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Lancets Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Lancets Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Lancets Sales Volume by Region (M Units): 2020 VS 2024 VS 2031
  • Table 46. Global Lancets Sales Volume by Region (2020-2025) & (M Units)
  • Table 47. Global Lancets Sales Volume by Region (2026-2031) & (M Units)
  • Table 48. Global Lancets Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Lancets Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Lancets Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Lancets Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Lancets Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Lancets Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Lancets Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Lancets Sales Volume, (2020-2025) & (M Units)
  • Table 56. Key Countries/Regions Lancets Sales Volume, (2026-2031) & (M Units)
  • Table 57. Roche Company Information
  • Table 58. Roche Introduction and Business Overview
  • Table 59. Roche Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Roche Lancets Product Offerings
  • Table 61. Roche Recent Development
  • Table 62. Lifescan Company Information
  • Table 63. Lifescan Introduction and Business Overview
  • Table 64. Lifescan Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Lifescan Lancets Product Offerings
  • Table 66. Lifescan Recent Development
  • Table 67. BD Company Information
  • Table 68. BD Introduction and Business Overview
  • Table 69. BD Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. BD Lancets Product Offerings
  • Table 71. BD Recent Development
  • Table 72. MTD Group Company Information
  • Table 73. MTD Group Introduction and Business Overview
  • Table 74. MTD Group Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. MTD Group Lancets Product Offerings
  • Table 76. MTD Group Recent Development
  • Table 77. Greiner Bio One Company Information
  • Table 78. Greiner Bio One Introduction and Business Overview
  • Table 79. Greiner Bio One Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Greiner Bio One Lancets Product Offerings
  • Table 81. Greiner Bio One Recent Development
  • Table 82. Owen Mumford Company Information
  • Table 83. Owen Mumford Introduction and Business Overview
  • Table 84. Owen Mumford Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Owen Mumford Lancets Product Offerings
  • Table 86. Owen Mumford Recent Development
  • Table 87. Cardinal Health Company Information
  • Table 88. Cardinal Health Introduction and Business Overview
  • Table 89. Cardinal Health Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Cardinal Health Lancets Product Offerings
  • Table 91. Cardinal Health Recent Development
  • Table 92. Ascensia Company Information
  • Table 93. Ascensia Introduction and Business Overview
  • Table 94. Ascensia Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. Ascensia Lancets Product Offerings
  • Table 96. Ascensia Recent Development
  • Table 97. Abbott Company Information
  • Table 98. Abbott Introduction and Business Overview
  • Table 99. Abbott Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. Abbott Lancets Product Offerings
  • Table 101. Abbott Recent Development
  • Table 102. B. Braun Company Information
  • Table 103. B. Braun Introduction and Business Overview
  • Table 104. B. Braun Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 105. B. Braun Lancets Product Offerings
  • Table 106. B. Braun Recent Development
  • Table 107. Terumo Company Information
  • Table 108. Terumo Introduction and Business Overview
  • Table 109. Terumo Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 110. Terumo Lancets Product Offerings
  • Table 111. Terumo Recent Development
  • Table 112. I-SENS Company Information
  • Table 113. I-SENS Introduction and Business Overview
  • Table 114. I-SENS Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 115. I-SENS Lancets Product Offerings
  • Table 116. I-SENS Recent Development
  • Table 117. Nipro Company Information
  • Table 118. Nipro Introduction and Business Overview
  • Table 119. Nipro Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 120. Nipro Lancets Product Offerings
  • Table 121. Nipro Recent Development
  • Table 122. ICU Medical Company Information
  • Table 123. ICU Medical Introduction and Business Overview
  • Table 124. ICU Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 125. ICU Medical Lancets Product Offerings
  • Table 126. ICU Medical Recent Development
  • Table 127. Sarstedt Company Information
  • Table 128. Sarstedt Introduction and Business Overview
  • Table 129. Sarstedt Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 130. Sarstedt Lancets Product Offerings
  • Table 131. Sarstedt Recent Development
  • Table 132. Sinocare Company Information
  • Table 133. Sinocare Introduction and Business Overview
  • Table 134. Sinocare Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 135. Sinocare Lancets Product Offerings
  • Table 136. Sinocare Recent Development
  • Table 137. Yueyue Medical Company Information
  • Table 138. Yueyue Medical Introduction and Business Overview
  • Table 139. Yueyue Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 140. Yueyue Medical Lancets Product Offerings
  • Table 141. Yueyue Medical Recent Development
  • Table 142. Tianjin Huahong Medical Company Information
  • Table 143. Tianjin Huahong Medical Introduction and Business Overview
  • Table 144. Tianjin Huahong Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 145. Tianjin Huahong Medical Lancets Product Offerings
  • Table 146. Tianjin Huahong Medical Recent Development
  • Table 147. Suzhou Shilai Medical Company Information
  • Table 148. Suzhou Shilai Medical Introduction and Business Overview
  • Table 149. Suzhou Shilai Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 150. Suzhou Shilai Medical Lancets Product Offerings
  • Table 151. Suzhou Shilai Medical Recent Development
  • Table 152. Shandong Lianfa Medical Company Information
  • Table 153. Shandong Lianfa Medical Introduction and Business Overview
  • Table 154. Shandong Lianfa Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 155. Shandong Lianfa Medical Lancets Product Offerings
  • Table 156. Shandong Lianfa Medical Recent Development
  • Table 157. Promisemed Company Information
  • Table 158. Promisemed Introduction and Business Overview
  • Table 159. Promisemed Lancets Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 160. Promisemed Lancets Product Offerings
  • Table 161. Promisemed Recent Development
  • Table 162. Key Raw Materials Lists
  • Table 163. Raw Materials Key Suppliers Lists
  • Table 164. Lancets Downstream Customers
  • Table 165. Lancets Distributors List
  • Table 166. Research Programs/Design for This Report
  • Table 167. Key Data Information from Secondary Sources
  • Table 168. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Lancets Product Picture
  • Figure 2. Global Lancets Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Lancets Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Lancets Sales Volume (2020-2031) & (M Units)
  • Figure 5. Global Lancets Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Lancets Report Years Considered
  • Figure 7. Global Lancets Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Lancets Players Sales Volume Ranking (2024) & (M Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Lancets Revenue in 2024
  • Figure 10. Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Safety Lancets Picture
  • Figure 12. Ordinary Lancets Picture
  • Figure 13. Global Lancets Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Lancets Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Lancets Sales Volume by Type (2020 VS 2024 VS 2031) & (M Units)
  • Figure 16. Global Lancets Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Lancets Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Blood Glucose Test
  • Figure 19. Product Picture of Newborn Screening
  • Figure 20. Product Picture of Rapid Blood Test
  • Figure 21. Product Picture of Other
  • Figure 22. Global Lancets Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 23. Global Lancets Sales Value Market Share by Application, 2024 & 2031
  • Figure 24. Global Lancets Sales Volume by Application (2020 VS 2024 VS 2031) & (M Units)
  • Figure 25. Global Lancets Sales Volume Market Share by Application, 2024 & 2031
  • Figure 26. Global Lancets Price by Application (2020-2031) & (US$/Unit)
  • Figure 27. North America Lancets Sales Value (2020-2031) & (US$ Million)
  • Figure 28. North America Lancets Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Europe Lancets Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Europe Lancets Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Asia Pacific Lancets Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Asia Pacific Lancets Sales Value by Region (%), 2024 VS 2031
  • Figure 33. South America Lancets Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. South America Lancets Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Middle East & Africa Lancets Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. Middle East & Africa Lancets Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Key Countries/Regions Lancets Sales Value (%), (2020-2031)
  • Figure 38. Key Countries/Regions Lancets Sales Volume (%), (2020-2031)
  • Figure 39. United States Lancets Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. United States Lancets Sales Value by Type (%), 2024 VS 2031
  • Figure 41. United States Lancets Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Europe Lancets Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Europe Lancets Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Europe Lancets Sales Value by Application (%), 2024 VS 2031
  • Figure 45. China Lancets Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. China Lancets Sales Value by Type (%), 2024 VS 2031
  • Figure 47. China Lancets Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Japan Lancets Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. Japan Lancets Sales Value by Type (%), 2024 VS 2031
  • Figure 50. Japan Lancets Sales Value by Application (%), 2024 VS 2031
  • Figure 51. South Korea Lancets Sales Value, (2020-2031) & (US$ Million)
  • Figure 52. South Korea Lancets Sales Value by Type (%), 2024 VS 2031
  • Figure 53. South Korea Lancets Sales Value by Application (%), 2024 VS 2031
  • Figure 54. Southeast Asia Lancets Sales Value, (2020-2031) & (US$ Million)
  • Figure 55. Southeast Asia Lancets Sales Value by Type (%), 2024 VS 2031
  • Figure 56. Southeast Asia Lancets Sales Value by Application (%), 2024 VS 2031
  • Figure 57. India Lancets Sales Value, (2020-2031) & (US$ Million)
  • Figure 58. India Lancets Sales Value by Type (%), 2024 VS 2031
  • Figure 59. India Lancets Sales Value by Application (%), 2024 VS 2031
  • Figure 60. Lancets Industrial Chain
  • Figure 61. Lancets Manufacturing Cost Structure
  • Figure 62. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 63. Bottom-up and Top-down Approaches for This Report
  • Figure 64. Data Triangulation
  • Figure 65. Key Executives Interviewed